The Clinical Impact of Rapid Molecular Microbiological Diagnostics for Pathogen and Resistance Gene Identification in Patients With Sepsis: A Systematic Review

Abstract Fast microbiological diagnostics (MDx) are needed to ensure early targeted antimicrobial treatment in sepsis. This systematic review focuses on the impact on antimicrobial management and patient outcomes of MDx for pathogen and resistance gene identification compared with blood cultures. PubMed was searched for clinical studies using either whole blood directly or after short-term incubation. Twenty-five articles were retrieved describing the outcomes of 8 different MDx. Three interventional studies showed a significant increase in appropriateness of antimicrobial therapy and a nonsignificant change in time to appropriate therapy. Impact on mortality was conflicting. Length of stay was significantly lower in 2 studies. A significant decrease in antimicrobial cost was demonstrated in 6 studies. The limitations of this systematic review include the low number and observed heterogeneity of clinical studies. In conclusion, potential benefits of MDx regarding antimicrobial management and some patient outcomes were reported. More rigorous intervention studies are needed focusing on the direct benefits for patients.

[1]  Natalie S Blencowe,et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.

[2]  V. Weber,et al.  Pathogen enrichment from human whole blood for the diagnosis of bloodstream infection: Prospects and limitations. , 2019, Diagnostic microbiology and infectious disease.

[3]  M. Pfaller,et al.  Impact of rapid, culture-independent diagnosis of candidaemia and invasive candidiasis in a community health system , 2018, The Journal of antimicrobial chemotherapy.

[4]  M. Martínez-Jiménez,et al.  T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study , 2018, The Journal of antimicrobial chemotherapy.

[5]  D. Pestaña,et al.  T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study , 2018, The Journal of antimicrobial chemotherapy.

[6]  Mathias W Pletz,et al.  Bakterielle Sepsis , 2017, Der Anaesthesist.

[7]  M. Dryden,et al.  Can rapid negative exclusion of blood cultures by a molecular method, enzyme template generation and amplification technique (Cognitor® Minus), aid antimicrobial stewardship? , 2017, The International journal of pharmacy practice.

[8]  T. Kozel,et al.  Point-of-Care Testing for Infectious Diseases: Past, Present, and Future , 2017, Journal of Clinical Microbiology.

[9]  C. Brun-Buisson,et al.  Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial , 2017, Intensive Care Medicine.

[10]  R. Sampath,et al.  The detection of microbial DNA but not cultured bacteria is associated with increased mortality in patients with suspected sepsis-a prospective multi-centre European observational study. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  Sangeeta Mehta,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[12]  Dena R Shibib,et al.  The new frontier of diagnostics: Molecular assays and their role in infection prevention and control , 2017, American Journal of Infection Control.

[13]  B. Long,et al.  Best Clinical Practice: Blood Culture Utility in the Emergency Department. , 2016, The Journal of emergency medicine.

[14]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[15]  C. Suetens,et al.  Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study , 2016, PLoS medicine.

[16]  Stefan Hagel,et al.  The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  R. Hu,et al.  Time to positivity of blood culture and its prognostic value in bloodstream infection , 2016, European Journal of Clinical Microbiology & Infectious Diseases.

[18]  B. Bhat,et al.  Syndrome Evaluation System (SES) versus Blood Culture (BACTEC) in the Diagnosis and Management of Neonatal Sepsis - A Randomized Controlled Trial , 2016, The Indian Journal of Pediatrics.

[19]  M. Doğan,et al.  A Multicenter Evaluation of Blood Culture Practices, Contamination Rates, and the Distribution of Causative Bacteria , 2016, Jundishapur journal of microbiology.

[20]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[21]  D. Ecker,et al.  Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections* , 2015, Critical care medicine.

[22]  K. Wernecke,et al.  Randomized controlled clinical trial evaluating multiplex polymerase chain reaction for pathogen identification and therapy adaptation in critical care patients with pulmonary or abdominal sepsis , 2015, The Journal of international medical research.

[23]  L. May,et al.  Evaluation of real-time PCR and pyrosequencing for screening incubating blood culture bottles from adults with suspected bloodstream infection. , 2015, Diagnostic microbiology and infectious disease.

[24]  M. Landini,et al.  Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study , 2014, Expert review of molecular diagnostics.

[25]  M. Ivanova,et al.  Diagnostic performance and therapeutic impact of LightCycler SeptiFast assay in patients with suspected sepsis. , 2013, European journal of microbiology & immunology.

[26]  K. Reinhart,et al.  Attributable costs of patients with candidemia and potential implications of polymerase chain reaction-based pathogen detection on antifungal therapy in patients with sepsis. , 2013, Journal of critical care.

[27]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[28]  J. Mar,et al.  Cost Analysis of Real-Time Polymerase Chain Reaction Microbiological Diagnosis in Patients with Septic Shock , 2012, Anaesthesia and intensive care.

[29]  M. Bauer,et al.  Evaluation of a Polymerase Chain Reaction Assay for Pathogen Detection in Septic Patients under Routine Condition: An Observational Study , 2012, PloS one.

[30]  G. Martin.  Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes , 2012, Expert review of anti-infective therapy.

[31]  D. Greenhalgh,et al.  Multiplex polymerase chain reaction pathogen detection in patients with suspected septicemia after trauma, emergency, and burn surgery. , 2012, Surgery.

[32]  H. Lippert,et al.  PCR-based rapid sepsis diagnosis effectively guides clinical treatment in patients with new onset of SIRS , 2012, Langenbeck's Archives of Surgery.

[33]  J. Buer,et al.  Results and Relevance of Molecular Detection of Pathogens by SeptiFast – A Retrospective Analysis in 75 Critically Ill Children , 2012, Klinische Pädiatrie.

[34]  M. Tormo,et al.  Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[35]  J. Timsit,et al.  Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis. , 2010, The Journal of infection.

[36]  S. Nseir,et al.  Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[37]  M. Bauer,et al.  A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis , 2010, Intensive Care Medicine.

[38]  L. Lehmann,et al.  Potential clinical utility of polymerase chain reaction in microbiological testing for sepsis , 2009, Critical care medicine.

[39]  Sylvia Siebig,et al.  Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis , 2009, BMC infectious diseases.

[40]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, PloS one.

[41]  N. Wellinghausen,et al.  Rapid detection of pathogens in blood culture bottles by real-time PCR in conjunction with the pre-analytic tool MolYsis. , 2008, The Journal of infection.

[42]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[43]  G Sherman,et al.  The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.

[44]  E. Mylonakis,et al.  The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  D. Pieper,et al.  Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. , 2016, Current topics in microbiology and immunology.